EXOZ Stock: Price, Forecast, Financials & AI Analysis

High

Open

VWAP

Vol

Mkt Cap

Low

Amount

EV/EBITDA(TTM)

Total Shares

EV/OCF(TTM)

P/S(TTM)

Valuation Metrics

The current forward P/E ratio for eXoZymes Inc (EXOZ.O) is 0.00, compared to its 5-year average forward P/E of 0.00. For a more detailed relative valuation and DCF analysis to assess eXoZymes Inc 's fair value, click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.

N/A

5Y Average PE

0.00

Current PE

0.00

Overvalued PE

0.00

Undervalued PE

0.00

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.

N/A

5Y Average EV/EBITDA

0.00

Current EV/EBITDA

0.00

Overvalued EV/EBITDA

0.00

Undervalued EV/EBITDA

0.00

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.

N/A

5Y Average PS

0.20

Current PS

0.00

Overvalued PS

1.84

Undervalued PS

-1.44

Financials

Annual

Quarterly

N/A

Operating Profit

N/A

Net Income after Tax

N/A

EPS - Diluted

N/A

Free Cash Flow

Trading Trends

Insider

Insiders are Neutral. There are no significant trading trends over the last month.

Sold

Bought

Hedge Fund

Hedge Funds are Neutral. There are no significant trading trends over the last quarter.

Sold

Bought

Congress Trading

Congress are Neutral. There are no significant trading trends over the last month.

Sold

Bought

Insider

Insiders are Neutral. There are no significant trading trends over the last month.

Sold

Bought

EXOZ News & Events

Events Timeline

No data

News

5.0

07-07NASDAQ.COM

Monday 7/7 Insider Buying Report: EXOZ, IAF

3.5

04-21Newsfilter

Bringing clarity and precision to the cell-free space by introducing exozymes

5.0

04-10Newsfilter

BioClick – an enzyme engineering game-changer, launched by eXoZymes and supported by a $300K NIH grant

People Also Watch

Frequently Asked Questions

What is eXoZymes Inc (EXOZ) stock price today?

The current price of EXOZ is 14.25 USD — it has decreased -0.63 % in the last trading day.

What is eXoZymes Inc (EXOZ)'s business?

eXoZymes Inc, formerly Invizyne Technologies, Inc., is an artificial intelligence (AI) engineered enzyme that can transform sustainable feedstock into essential chemicals, medicines, and biofuels. The Company has developed a platform that offers the tools and insight to control and optimize nature’s own biological processes, enabling their partners to replace traditional chemical production methods with a new sustainable and non-polluting alternative. The Exozymes are advanced enzymes engineered using AI to thrive in a bioreactor outside of living cells.

What is the price predicton of EXOZ Stock?

Wall Street analysts forecast EXOZ stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for EXOZ is USD with a low forecast of USD and a high forecast of USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

What is eXoZymes Inc (EXOZ)'s revenue for the last quarter?

eXoZymes Inc revenue for the last quarter amounts to -2.52M USD, increased 56.49 % YoY.

What is eXoZymes Inc (EXOZ)'s earnings per share (EPS) for the last quarter?

eXoZymes Inc. EPS for the last quarter amounts to -1870018.00 USD, increased 245.33 % YoY.

What changes have occurred in the market's expectations for eXoZymes Inc (EXOZ)'s fundamentals?

The market is revising No Change the revenue expectations for EXOZ for , with the revenue forecasts being adjusted by % over the past three months. During the same period, the stock price has changed by 5.63%.

How many employees does eXoZymes Inc (EXOZ). have?

eXoZymes Inc (EXOZ) has 31 emplpoyees as of December 15 2025.

What is eXoZymes Inc (EXOZ) market cap?

Today EXOZ has the market capitalization of 120.27M USD.